These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28271714)

  • 1. Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release.
    Wang H; Wu J; Xie K; Fang T; Chen C; Xie H; Zhou L; Zheng S
    ACS Appl Mater Interfaces; 2017 Mar; 9(12):10567-10576. PubMed ID: 28271714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.
    Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H
    Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic assembly of small-molecule prodrug cocktail nanoparticles with high reproducibility for synergistic combination of cancer therapy.
    Li T; Huang J; Wang M; Wang H
    Int J Pharm; 2021 Oct; 608():121088. PubMed ID: 34530101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.
    Wang H; Chen J; Xu C; Shi L; Tayier M; Zhou J; Zhang J; Wu J; Ye Z; Fang T; Han W
    Theranostics; 2017; 7(15):3638-3652. PubMed ID: 29109766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy.
    Gu Y; Ma J; Fu Z; Xu Y; Gao B; Yao J; Xu W; Chu K; Chen J
    Int J Nanomedicine; 2019; 14():8805-8818. PubMed ID: 31806973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics.
    Ling L; Ismail M; Shang Z; Hu Y; Li B
    Int J Pharm; 2020 Mar; 577():119049. PubMed ID: 31982558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
    Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
    ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
    Wang Z; Chen J; Little N; Lu J
    Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy.
    Zhao D; Tao W; Li S; Li L; Sun Y; Li G; Wang G; Wang Y; Lin B; Luo C; Wang Y; Cheng M; He Z; Sun J
    Nanoscale Horiz; 2020 May; 5(5):886-894. PubMed ID: 32219262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy.
    Wang H; Xie H; Wu J; Wei X; Zhou L; Xu X; Zheng S
    Angew Chem Int Ed Engl; 2014 Oct; 53(43):11532-7. PubMed ID: 25196427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
    Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
    Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoactivatable Prodrug-Backboned Polymeric Nanoparticles for Efficient Light-Controlled Gene Delivery and Synergistic Treatment of Platinum-Resistant Ovarian Cancer.
    Zhang Q; Kuang G; He S; Lu H; Cheng Y; Zhou D; Huang Y
    Nano Lett; 2020 May; 20(5):3039-3049. PubMed ID: 32250633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Sensitive Charge-Conversional Polymeric Prodrug for Efficient Codelivery of Demethylcantharidin and Doxorubicin.
    Wu Y; Zhou D; Zhang Q; Xie Z; Chen X; Jing X; Huang Y
    Biomacromolecules; 2016 Aug; 17(8):2650-61. PubMed ID: 27384255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma.
    Wang H; Zhou L; Xie K; Wu J; Song P; Xie H; Zhou L; Liu J; Xu X; Shen Y; Zheng S
    Theranostics; 2018; 8(14):3949-3963. PubMed ID: 30083272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
    Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
    Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
    Zhang X; Li J; Yan M
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.